Sanofi request sparks new warning

Posted 22 November 2024 PM

A request from Sanofi to add new warnings on the risks of giving Phenergan to children under the age of six following an internal investigation will soon apply to all generics of the oral antihistamine in Australia.

Phenergan, which contains the active promethazine hydrochloride, is used to treat a range of conditions including allergies, hay fever and nausea, as well as for short-term sedation.

To see the whole article, please login